Dow Jones

38 834,86

0,15%

DAX

Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Pharmaxis Limited - Sponsored Adr (Australia) (MM) (PXSL)
Pharmaxis Limited - Sponsored Adr (Australia) (MM) (PXSL) Actualités

PXSL

Pharmaxis Limited - Sponsored Adr (Australia) (MM) (PXSL)

Pharmaxis Limited - Sponsored Adr (Australia) (MM)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:PXSL

1 2 3 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
22/07/2009	12h04	Edgar (US Regulatory)	Report of Foreign Issuer (6-K)	NASDAQ:PXSL	Pharmaxis Limited - Sponsored Adr (Australia) (MM)
13/07/2009	01h22	PR Newswire (US)	Pharmaxis to Voluntarily De-List from Nasdaq	NASDAQ:PXSL	Pharmaxis Limited - Sponsored Adr (Australia) (MM)
30/06/2009	02h12	PR Newswire (US)	Pharmaxis Closes Share Purchase Plan	NASDAQ:PXSL	Pharmaxis Limited - Sponsored Adr (Australia) (MM)
19/06/2009	14h56	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (D)	NASDAQ:PXSL	Pharmaxis Limited - Sponsored Adr (Australia) (MM)
16/06/2009	03h11	PR Newswire (US)	Phase 3 Cystic Fibrosis Trial Results Presented at European Conference	NASDAQ:PXSL	Pharmaxis Limited - Sponsored Adr (Australia) (MM)
04/06/2009	02h19	PR Newswire (US)	Pharmaxis Announces Placement of $47 Million and Share Purchase Plan	NASDAQ:PXSL
14/05/2009	01h33	PR Newswire (US)	U.S. FDA Accepts Aridol(TM) New Drug Application for Review	NASDAQ:PXSL
04/05/2009	10h02	PR Newswire (US)	Pharmaxis Announces Positive Results of Phase 3 Cystic Fibrosis Trial	NASDAQ:PXSL	Pharmaxis Limited - Sponsored Adr (Australia) (MM)
07/04/2009	01h02	PR Newswire (US)	New Pharmaxis Board Appointment	NASDAQ:PXSL	Pharmaxis Limited - Sponsored Adr (Australia) (MM)
06/04/2009	09h52	PR Newswire (US)	Pharmaxis Investor Conference Call	NASDAQ:PXSL
01/04/2009	00h58	PR Newswire (US)	Pharmaxis Announces Milestone in Phase III Trial for Cystic Fibrosis	NASDAQ:PXSL	Pharmaxis Limited - Sponsored Adr (Australia) (MM)
11/03/2009	07h10	PR Newswire (US)	Pharmaxis Appoints French Distributor for Aridol(TM)	NASDAQ:PXSL	Pharmaxis Limited - Sponsored Adr (Australia) (MM)
03/03/2009	15h14	PR Newswire (US)	Pharmaxis Announces NDA Filing for Aridol(TM) (Mannitol Bronchial Challenge Test)	NASDAQ:PXSL
01/03/2009	23h41	PR Newswire (US)	Pharmaxis Announces New Drug Application Submission for Aridol(TM)	NASDAQ:PXSL
17/02/2009	14h22	Edgar (US Regulatory)	Amended Statement of Ownership (SC 13G/A)	NASDAQ:PXSL	Pharmaxis Limited - Sponsored Adr (Australia) (MM)
17/02/2009	02h04	PR Newswire (US)	Pharmaxis Builds Senior Management Team	NASDAQ:PXSL	Pharmaxis Limited - Sponsored Adr (Australia) (MM)
20/10/2008	01h25	PR Newswire (US)	Pharmaxis Aridol Approved for Sale in Switzerland	NASDAQ:PXSL	Pharmaxis Limited - Sponsored Adr (Australia) (MM)
03/10/2008	12h02	Edgar (US Regulatory)	Pharmaxis Ltd. - Report of Foreign Issuer (6-K)	NASDAQ:PXSL	Pharmaxis Limited - Sponsored Adr (Australia) (MM)
03/10/2008	02h26	PR Newswire (US)	Pharmaxis Research Programs Highlighted at European Respiratory Society Congress	NASDAQ:PXSL
01/10/2008	02h19	PR Newswire (US)	ASX/NASDAQ Media Release: Pharmaxis Files First Marketing Application for Bronchitol in Australia	NASDAQ:PXSL	Pharmaxis Limited - Sponsored Adr (Australia) (MM)
16/09/2008	12h05	Edgar (US Regulatory)	Pharmaxis Ltd. - Annual and Transition Report (foreign private issuer) (20-F)	NASDAQ:PXSL	Pharmaxis Limited - Sponsored Adr (Australia) (MM)
04/09/2008	08h33	PR Newswire (US)	Second Pivotal Phase 3 Trial In Cystic Fibrosis Begins	NASDAQ:PXSL	Pharmaxis Limited - Sponsored Adr (Australia) (MM)
20/08/2008	04h07	PR Newswire (US)	12 Month Phase 3 Trial Finds Bronchitol Safe in Bronchiectasis	NASDAQ:PXSL	Pharmaxis Limited - Sponsored Adr (Australia) (MM)
18/08/2008	03h59	PR Newswire (US)	Bronchitol Phase 3 Cystic Fibrosis Trial Completes Recruitment	NASDAQ:PXSL	Pharmaxis Limited - Sponsored Adr (Australia) (MM)
12/08/2008	02h10	PR Newswire (US)	Bronchitol Cystic Fibrosis Dose Trial Results Positive	NASDAQ:PXSL	Pharmaxis Limited - Sponsored Adr (Australia) (MM)
20/06/2008	01h05	PR Newswire (US)	Pharmaxis Concludes Special Protocol Assessment with FDA for Bronchitol Phase 3 Trial	NASDAQ:PXSL	Pharmaxis Limited - Sponsored Adr (Australia) (MM)
17/06/2008	03h20	PR Newswire (US)	Pharmaxis Establishes Named Patient Program for Bronchitol	NASDAQ:PXSL	Pharmaxis Limited - Sponsored Adr (Australia) (MM)
12/06/2008	01h47	PR Newswire (US)	Pharmaxis Long-Term Safety Study of Bronchitol Completes	NASDAQ:PXSL	Pharmaxis Limited - Sponsored Adr (Australia) (MM)
19/05/2008	04h13	PR Newswire (US)	Pharmaxis' Aridol Authorised for Sale in Germany	NASDAQ:PXSL	Pharmaxis Limited - Sponsored Adr (Australia) (MM)
01/05/2008	13h01	PR Newswire (US)	Regulatory Path for Bronchitol in Bronchiectasis	NASDAQ:PXSL